The new guidance, published in the Journal of the American College of Cardiology, covers a variety of topics, including thoracic aortic disease, peripheral artery disease, shared decision-making and cardiac imaging.

The new study, presented at the AHA Scientific Sessions 2022 conference in Chicago, focused on data from more than 2,000 patients. 

Two late-breaking clinical trials presented at the VIVA Foundation’s VIVA22 conference in Las Vegas highlighted the impact drug-coated balloons can make on patient outcomes. 

New research out of Mayo Clinic found that clinicians who listened to AI-based treatment recommendations were more successful at identifying patients with low ejection fraction. 

Atrial fibrillation and peripheral artery disease, for example, are both predictors of mortality among women, but not men. 

Patients impacted by this recall are advised to speak with a physician about how to proceed. 

“The findings of this study are important because they provide fresh evidence that the use of e-cigarettes could interfere with normal heart rhythms—something we did not know before,” according to one specialist. 

“Without a clear reference standard technique that optimizes patient outcomes, device selection is based on availability and physician-driven selection, which can substantially impact procedural costs,” authors of a new cost analysis in Clinical Radiology stated.

A three-site imaging operation in Hawaii has been turning away patients since Oct. 20 due to what its management initially described as unspecified “technical difficulties.”